Retroperitoneal fibrosis caused by pergolide in a patient with Parkinson's disease

Netherlands Journal of Medicine

Volumn 62, Issue 10, 2004, Pages 389-392

  Bilici, Ahmetknower ^a   Karadag, B ^a   Doventas, A ^a   Suna Erdincler, D ^a   Cetinkaya, S ^b   Ogut, G ^b   Tezcan, V ^a   Beger, T ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; BENSERAZIDE PLUS LEVODOPA; BROMOCRIPTINE; CREATININE; DOPAMINE RECEPTOR STIMULATING AGENT; NITROGEN; PERGOLIDE; SELEGILINE; UREA; WARFARIN;

AGED; ANOREXIA; ARTICLE; CASE REPORT; CLINICAL EXAMINATION; COMPUTER ASSISTED TOMOGRAPHY; DEEP VEIN THROMBOSIS; DRUG WITHDRAWAL; ECHOGRAPHY; FEMALE; HUMAN; HYDROURETER; HYPERTENSION; KIDNEY DISEASE; KIDNEY FUNCTION; LEG EDEMA; LOW BACK PAIN; NAUSEA AND VOMITING; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PLEURA EFFUSION; RETROPERITONEAL FIBROSIS; STEREOTAXIC SURGERY; THORACOCENTESIS; THORAX RADIOGRAPHY; TREATMENT OUTCOME; URETER OBSTRUCTION; URETER STENT;

AGED; ANTIPARKINSON AGENTS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PERGOLIDE; RETROPERITONEAL FIBROSIS;

EID: 9244261012     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Koep L, Zuidema GD. The clinical significance of retroperitoneal fibrosis. Surgery 1977;81:250-7.
2. Monev S. Idiopathic retroperitoneal fibrosis: prompt diagnosis preserves organ function. Cleve Clin J Med 2002;69:160-6.
3. Elkind AH, Friedman AP, Bachman A, Siegelman SS, Sacks OW. Silent retroperitoneal fibrosis associated with methysergicle therapy. JAMA 1968;206:1041-4.
4. Herzog A, Minne H, Ziegler R. Retroperitoneal fibrosis in a patient with macroprolactinoma treated with bromocriptine. BMJ 1989;298:1315.
5. Watts RL. The role of dopamine agonists in early Parkinson's disease. Neurology 1997;49(suppl 1):34-48.
6. Jimenez-Jimenez FJ, Lopez-Alvarez J, Sanchez-Chapado M, et al. Retroperitoneal fibrosis in a patient with Parkinson's disease treated with pergolide. Clin Neuropharmacol 1995;18:277-9.
7. Kunkler RB, Osborn DE, Abbott RJ. Retroperitoneal fibrosis caused by treatment with pergolide in a patient Parkinson's disease. Br J Urol 1998;82:147.
8. Shaunak S, Wilkins A, Pilling JB, Dick DJ. Pericardial, retroperitoneal, and pleural fibrosis induced by pergolide. J Neurol Neurosurg Psychiatry 1999;66:79-81.
9. Mondal BK, Suri S. Pergolide-induced retroperitoneal fibrosis. Int J Clin Pract 2000;54:402.
10. Lund BC, Nieman RF, Perry PJ. Treatment of Parkinson's disease with ropinirole after pergolide-induced retroperitoneal fibrosis. Pharmocotherapy 1999;19:1437-8.
11. Shah LV, Carr DB. Case of hydronephrosis and retroperitoneal fibrosis. Ann Long-Term Care 2002;10:44-6.
12. Bommel EF van. Retroperitoneal fibrosis. Neth J Med 2002;60:231-42.
13. Lichon FS, Sequeria W, Pilloff A, Skosey JL. Retroperitoneal fibrosis associated with systemic lupus erythematosus: a case report and brief review. J Rheumatol 1984;11:373-4.
14. Littlejohn JO, Keystone EC. The association of retroperitoneal fibrosis with systemic vasculitis and HLA-B27: a case report and review of the literature. J Rheumatol 1981;8:665-9.
15. Onuigbo M, Lawrence K MSc, Park S. Retroperitoneal fibrosis: unusual cause of low back pain. Southern Med J 2001;94:735-7.
16. Degesys GE, Dunnick NR, Silverman PM, Cohan RH, Illescas FF, Castagno A. Retroperitoneal fibrosis: use of CT in distinguishing among possible causes. Am J Roentgenol 1986;146:57-60.
17. Arrive L, Hricak H, Tavares NJ, Miller TR. Malignant versus non-malignant retroperitoneal fibrosis: differentiation with MR imaging. Radiology 1989;172:139-43.
18. Puijenbroek EP, Stricker BH. Pergolide-induced pleuropulmonary fibrosis. Clin Neuropharmacol 2002;25:290-2.
19. Hoffman W, Trippel O. Retroperitoneal fibrosis: aetiological considerations. J Urol 1961;86:222-32.
20. Pfitzenmeyer P, Foucher P, Dennewald G, et al. Pleuropulmonary changes induced by ergoline drugs. Eur Respir J 1996;9:1013-9.
21. Al-Musawi D, Mitchenere P, Al-Akraa M. Idiopathic retroperitoneal fibrosis treated with tamoxifen only. Br J Urol 1998;82:442-3.
22. Cogan E, Fastrez R. Azathioprine: an alternative treatment for recurrent idiopathic retroperitoneal fibrosis. Arch Intern Med 1985;145:53-5.